Entheon Biomedical Corp. reported earnings results for the second quarter and six months ended May 31, 2024. For the second quarter, the company reported net loss was CAD 0.094563 million compared to CAD 0.035992 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the six months, net loss was CAD 0.16942 million compared to CAD 0.131622 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.02 a year ago.